We have located links that may give you full text access.
A quantitative analysis on the effect of COVID-19 in a private health insurance plan expenditure.
Quality & Quantity 2022 December 31
This paper explores the effect of COVID-19 on health care expenditure using data from a private Health Insurance Plan (HIP). As well known, at the beginning of the COVID-19 pandemic, governments had to rely on Non-Pharmaceutical Interventions against the spread of the virus. However, the stringency of lockdowns differed across space and time as governments had to adjust their strategy dynamically to the country-specific development of the crisis. These strategies have strongly changed the policyholders' behavior; however, after this period, a fundamental question is whether the policyholder behavior will return to a status quo (i.e. in traditional care delivery). We analyze these effects using a "pre-post" quantitative study using longitudinal data collected from 2017 to 2021. We consider as a consumption measure the health care expenditure amount within several types of health services, coming from a group of insured persons, followed overtime every quarter, and separating the effect per gender and age. Moving in this direction, the purpose of our contribution is to investigate if the traditional actuarial approach for assessing the loss cost, based on the Generalized Linear Models, could predict the effect on the health care expenditure due to COVID-19 and the capacity to which a HIP can anticipate these uncertainties. Our results provide a comprehensive picture of the different effects of COVID-19 on the health services offered by the HIP, as well as on the behavior ofpolicyholders during and after the pandemic period.
Full text links
Related Resources
Trending Papers
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app